SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $595,000 | +5.5% | 55,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $564,000 | -24.5% | 55,100 | -3.7% | 0.00% | 0.0% |
| Q2 2016 | $747,000 | -4.1% | 57,200 | -19.3% | 0.00% | 0.0% |
| Q1 2016 | $779,000 | +8.2% | 70,900 | -9.5% | 0.00% | 0.0% |
| Q4 2015 | $720,000 | +7.6% | 78,300 | -18.8% | 0.00% | 0.0% |
| Q3 2015 | $669,000 | -16.6% | 96,400 | +18.0% | 0.00% | -25.0% |
| Q2 2015 | $802,000 | +5.0% | 81,700 | -5.3% | 0.00% | +33.3% |
| Q1 2015 | $764,000 | -1.4% | 86,300 | -2.5% | 0.00% | 0.0% |
| Q4 2014 | $775,000 | -42.9% | 88,500 | -55.1% | 0.00% | 0.0% |
| Q3 2014 | $1,358,000 | +92.6% | 197,000 | +46.9% | 0.00% | 0.0% |
| Q2 2014 | $705,000 | +9.8% | 134,100 | -5.0% | 0.00% | 0.0% |
| Q1 2014 | $642,000 | -9.8% | 141,200 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $712,000 | -10.9% | 141,200 | -10.3% | 0.00% | -25.0% |
| Q3 2013 | $799,000 | +2.3% | 157,500 | 0.0% | 0.00% | +33.3% |
| Q2 2013 | $781,000 | – | 157,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |